John Payne, President and Chief Executive Officer of Zivo Bioscience Inc (ZIVO, Financial), purchased 6,343 shares of the company on October 16, 2024, according to a recent SEC filing. This transaction increased the insider's total holdings to 7,909 shares.
Zivo Bioscience Inc is engaged in the study and development of natural bioactive compounds derived from its proprietary algal cultures for use in health and wellness applications. The insider's recent purchase aligns with a pattern of buying activity over the past year, where the insider has acquired a total of 6,343 shares.
The company's shares were priced at $15.76 on the day of the transaction, placing the market cap of Zivo Bioscience Inc at approximately $70.938 million. This valuation and the insider's buying activity may be of interest to investors considering the stock's current GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow.
Over the past year, there have been eight insider buys and zero insider sells at Zivo Bioscience Inc. This trend in insider transactions can be visualized in the following chart:
This consistent buying activity could suggest a positive outlook from the insiders regarding the company's future performance.
For more detailed information on John Payne's trading activities, please visit his profile on GuruFocus.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
